Boehringer Ingelheim Animal Health USA Inc. Sustainability Profile
Boehringer Ingelheim Animal Health USA Inc., a subsidiary of the global pharmaceutical company Boehringer Ingelheim, is headquartered in the United States and operates extensively across North America. Founded in 1885, the company has established itself as a leader in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a diverse portfolio that includes vaccines, parasiticides, and therapeutics, Boehringer Ingelheim is renowned for its commitment to research and development, which drives the creation of unique products tailored to enhance animal well-being. The company’s dedication to advancing animal health has positioned it among the top players in the market, achieving significant milestones in veterinary medicine and animal care.
DitchCarbon Score
How does Boehringer Ingelheim Animal Health USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim Animal Health USA Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim Animal Health USA Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of C.H. Boehringer Sohn AG & Co. KG, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Boehringer Ingelheim Animal Health USA Inc. This lack of specific data suggests that the company may still be in the process of establishing its own emissions reporting and reduction strategies, or it may rely on broader corporate initiatives from its parent organisation. Given the industry's increasing focus on sustainability, it is essential for Boehringer Ingelheim Animal Health USA Inc. to develop and communicate clear climate commitments and reduction targets in alignment with global standards. This would not only enhance transparency but also contribute to the overall efforts in mitigating climate change impacts within the animal health sector.
How Carbon Intensive is Boehringer Ingelheim Animal Health USA Inc.'s Industry?
How Carbon Intensive is Boehringer Ingelheim Animal Health USA Inc.'s Location?
Boehringer Ingelheim Animal Health USA Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boehringer Ingelheim Animal Health USA Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
